Margaret Smith Bell

Insider Reports History

Location
New York, NY
Signature
/s/ Jessica Morris, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Margaret Smith Bell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tonix Pharmaceuticals Holding Corp. Director Common Stock, par value $0.001 0 $0 $0.15 05 Feb 2025 Direct
Tonix Pharmaceuticals Holding Corp. Director Stock Option 104,621 23 May 2024 Direct
Tonix Pharmaceuticals Holding Corp. Director Stock Option 10,000 13 May 2025 Direct

Insider Reports Filed by Margaret Smith Bell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNXP Tonix Pharmaceuticals Holding Corp. 13 May 2025 1 $0 4 Director 15 May 2025, 17:00
TNXP Tonix Pharmaceuticals Holding Corp. 05 Feb 2025 1 $0 4 Director 28 Feb 2025, 17:32
TNXP Tonix Pharmaceuticals Holding Corp. 23 May 2024 1 $0 4 Director 24 May 2024, 17:05
TNXP Tonix Pharmaceuticals Holding Corp. 08 May 2023 1 $0 4 Director 10 May 2023, 17:14
TNXP Tonix Pharmaceuticals Holding Corp. 09 May 2022 1 $0 4 Director 11 May 2022, 17:44
TNXP Tonix Pharmaceuticals Holding Corp. 10 May 2021 1 $0 4 Director 12 May 2021, 16:42